Zhengye Biotechnology (ZYBT) Competitors $2.68 +0.13 (+5.10%) As of 10/3/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYBT vs. VCEL, EWTX, BHVN, PAHC, AVDL, ARDX, SDGR, ABCL, COGT, and JANXShould you be buying Zhengye Biotechnology stock or one of its competitors? The main competitors of Zhengye Biotechnology include Vericel (VCEL), Edgewise Therapeutics (EWTX), Biohaven (BHVN), Phibro Animal Health (PAHC), Avadel Pharmaceuticals (AVDL), Ardelyx (ARDX), Schrodinger (SDGR), AbCellera Biologics (ABCL), Cogent Biosciences (COGT), and Janux Therapeutics (JANX). These companies are all part of the "pharmaceutical products" industry. Zhengye Biotechnology vs. Its Competitors Vericel Edgewise Therapeutics Biohaven Phibro Animal Health Avadel Pharmaceuticals Ardelyx Schrodinger AbCellera Biologics Cogent Biosciences Janux Therapeutics Vericel (NASDAQ:VCEL) and Zhengye Biotechnology (NASDAQ:ZYBT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation. Do analysts recommend VCEL or ZYBT? Vericel currently has a consensus target price of $60.40, indicating a potential upside of 86.19%. Given Vericel's stronger consensus rating and higher probable upside, analysts plainly believe Vericel is more favorable than Zhengye Biotechnology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vericel 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Zhengye Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is VCEL or ZYBT more profitable? Vericel has a net margin of 2.85% compared to Zhengye Biotechnology's net margin of 0.00%. Vericel's return on equity of 2.47% beat Zhengye Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Vericel2.85% 2.47% 1.69% Zhengye Biotechnology N/A N/A N/A Does the media favor VCEL or ZYBT? In the previous week, Vericel and Vericel both had 1 articles in the media. Vericel's average media sentiment score of 0.93 beat Zhengye Biotechnology's score of 0.00 indicating that Vericel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vericel 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zhengye Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, VCEL or ZYBT? Vericel has higher revenue and earnings than Zhengye Biotechnology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVericel$237.22M6.90$10.36M$0.12270.33Zhengye Biotechnology$25.53M4.95$1.55MN/AN/A SummaryVericel beats Zhengye Biotechnology on 10 of the 10 factors compared between the two stocks. Get Zhengye Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYBT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZYBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYBT vs. The Competition Export to ExcelMetricZhengye BiotechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$120.27M$3.33B$6.09B$10.57BDividend YieldN/A2.27%5.68%4.70%P/E RatioN/A22.1477.6926.70Price / Sales4.95406.36576.73177.80Price / Cash24.7547.2037.7961.25Price / Book2.639.9312.546.56Net Income$1.55M-$52.80M$3.31B$277.61M7 Day Performance45.65%5.22%4.24%2.40%1 Month Performance-65.95%13.01%7.80%9.29%1 Year PerformanceN/A25.18%71.36%31.21% Zhengye Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYBTZhengye BiotechnologyN/A$2.68+5.1%N/AN/A$120.27M$25.53M0.00278VCELVericel3.3483 of 5 stars$31.21-1.9%$60.40+93.5%-21.5%$1.61B$249.12M260.11300EWTXEdgewise Therapeutics2.9706 of 5 stars$15.09-0.1%$40.55+168.7%-41.2%$1.59BN/A-9.7460Gap UpBHVNBiohaven3.1686 of 5 stars$14.15-4.7%$48.85+245.2%-66.1%$1.57BN/A-1.85239PAHCPhibro Animal Health4.5773 of 5 stars$38.42+0.1%$28.40-26.1%+81.4%$1.56B$1.30B32.562,475AVDLAvadel Pharmaceuticals2.9879 of 5 stars$15.81-1.2%$20.86+31.9%+17.2%$1.55B$221.08M-527.0070ARDXArdelyx4.4247 of 5 stars$6.15-1.1%$11.70+90.2%-21.0%$1.50B$333.61M-26.7490SDGRSchrodinger3.2427 of 5 stars$19.06-3.3%$27.83+46.0%+18.1%$1.45B$207.54M-7.69790Positive NewsAnalyst DowngradeABCLAbCellera Biologics3.049 of 5 stars$4.90+1.4%$8.00+63.3%+137.9%$1.44B$28.83M-8.91500News CoverageGap UpHigh Trading VolumeCOGTCogent Biosciences2.6707 of 5 stars$12.94+3.4%$20.00+54.6%+49.4%$1.42BN/A-7.2780JANXJanux Therapeutics2.5179 of 5 stars$22.98-2.3%$78.31+240.8%-45.7%$1.41B$439K-12.7730Positive News Related Companies and Tools Related Companies VCEL Alternatives EWTX Alternatives BHVN Alternatives PAHC Alternatives AVDL Alternatives ARDX Alternatives SDGR Alternatives ABCL Alternatives COGT Alternatives JANX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYBT) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThese financial titans stride the earth, invisibleUBS says millionaire ranks have surged 5-fold — but many of these new millionaires aren’t tech moguls or Wall ...Porter & Company | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zhengye Biotechnology Holding Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zhengye Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZYBT Stock Alerts